Peng, Xiaowei <br/><br/>
Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.  [electronic resource] 

 -  Anti-cancer drugs  Apr 2010 
 - 381-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5741 
<br/><br/><label>Standard No.: </label>10.1097/CAD.0b013e3283363980  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma--drug therapy<br/>Cell Line, Tumor<br/>Cisplatin--therapeutic use<br/>Drug Resistance, Neoplasm--drug effects<br/>Humans<br/>Nasopharyngeal Neoplasms--drug therapy<br/>Paclitaxel--therapeutic use<br/>Repressor Proteins--drug effects<br/>Signal Transduction--drug effects<br/>Thrombospondin 1--metabolism<br/>Up-Regulation--drug effects